Pfizer Limited
The Capital, 1802/1901,
Plot No. C - 70, G Block, Bandra Kurla Complex,
Bandra (East), Mumbai 400 051.
Tel : +91 22 6693 2000 Fax : +91 22 2654 0274
February 1, 2025 | |
The Corporate Relationship Dept. | The Manager, Listing Dept. |
BSE Limited | The National Stock Exchange of India Ltd. |
1st Floor, P.J.Towers | Exchange Plaza, 5th Floor, Plot No. C/1, |
Dalal Street, Fort | G Block Bandra-Kurla Complex, Bandra (E) |
Mumbai - 400 001 | Mumbai - 400 051 |
Scrip Code: 500680 | Scrip Symbol: PFIZER |
Dear Sirs, |
Sub: Integrated Filing (financial) for the quarter and nine months ended December 31, 2024.
Pursuant to the Securities and Exchange Board of India circular dated December 31, 2024, we attached herewith the Integrated Filing (Financial) for the quarter and nine months ended December 31, 2024.
We request you to kindly take the same on record.
Thanking you,
Yours truly,
For Pfizer Limited
PRAJEET
NAIR
Prajeet Nair
Digitally signed by
PRAJEET NAIR Date: 2025.02.01 13:15:49 +05'30'
Director - Corporate Services & Company Secretary
Cc.: National Securities Depository Limited (NSDL)
Central Depository Services (India) Limited (CDSL)
KFin Technologies Limited
CIN: L24231MH1950PLC008311
Email ID: contactus.india@pfizer.com
Website: www.pfizerltd.co.in
- STATEMENT ON DEVIATION OR VARIATION FOR PROCEEDS OF PUBLIC ISSUE, RIGHTS ISSUE, PREFERENTIAL ISSUE, QUALIFIED INSTITUTIONS PLACEMENT ETC: Not applicable
- FORMAT FOR DISCLOSING OUTSTANDING DEFAULT ON LOANS AND DEBT SECURITIES: Not applicable
- FORMAT FOR DISCLOSURE OF RELATED PARTY TRANSACTIONS (APPLICABLE ONLY FOR HALF-YEARLY FILINGS i.e 2ND AND 4TH QUARTER): Not applicable
- STATEMENT ON IMPACT OF AUDIT QUALIFICATIONS (FOR AUDIT REPORT WITH MODIFIED OPINION) SUBMITTED ALONG WITH ANNUAL AUDITED FINANCIAL RESULTS (STANDALONE AND CONSOLIDATED SEPARATELY) (APPLICABLE ONLY FOR ANNUAL FILING i.e 4TH QUARTER): Not applicable